Relish Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on July 15, 2016, to change the name of the Company, to open division of Company, to increase borrowing power of Board of Directors of the Company, to decide date, time and venue for Annual General Meeting of members of the Company, and to decide date of Book Closure.
The above information is a part of company’s filings submitted to BSE.